|POZEN Inc. CEO to Present at Piper Jaffray Health Care Conference|
CHAPEL HILL, N.C., Jan. 31 /PRNewswire/ -- POZEN Inc. (Nasdaq: POZN), a pharmaceutical development company with a portfolio of product candidates for the treatment of migraine, announced that John R. Plachetka, Pharm. D., the company's chairman, president and chief executive officer, will make a presentation to investors and financial analysts during the U.S. Bancorp. Piper Jaffray Health Care Conference on Thursday, February 1, 2001, at 9:30 a.m. EST. A live webcast will be accessible through the following link:
North Carolina-based POZEN Inc. is a pharmaceutical development company committed to building a portfolio of products with significant commercial potential in select therapeutic areas. The company's initial focus is migraine, where it has built a robust portfolio of four product candidates through a combination of innovation and in-licensing. The company's common stock is traded on The Nasdaq Stock Market under the symbol "POZN."
POZEN is on the Internet at http://www.pozen.com .